Cognition Therapeutics aims to stop memory loss with breakthrough Alzheimer’s drug

12.20.16

Cognition Therapeutics Alzheimer’s drug CT1812 is in a new round of clinical testing to see how it affects other medications being taken by Alzheimer’s patients in the US.